The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Capped F10, a novel DNA directed fluoropyrimidine, in TP53 mutated acute myeloid leukemia (AML).

Timothy S.  Pardee

Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Genentech

Research Funding - Karyopharm Therapeutics

Patents, Royalties, Other Intellectual Property - Named on a provisional patent on the use of KPC34 for the treatment of acute leukemias.

Charles  Okechukwu

No Relationships to Disclose

Kristin  Pladna

No Relationships to Disclose

William  Gmeiner

Leadership - Deep Creek Pharma

Stock and Other Ownership Interests  - Deep Creek Pharma